跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Monnax Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Monnax Plus
Approved
STANDARD
Monnax Plus
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8c59c5e3c032ac59
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
8c59c5e3c032ac59
Drug Approval Philippines Name
Monnax Plus
Product Name
Monnax Plus
Registration Number
DR-XY26946
Brand Name
Monnax Plus
Generic Name
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
Dosage Form
Suspension
Dosage Strength
225 mg/200 mg/25 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Medhaus Pharma, Inc.
Issuance Date
26 March 2021
Expiry Date
20 April 2026
Pharmacologic Category
Antacid/Antiflatulent
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8c59c5e3c032ac59
Type
Standard
Back to Philippines FDA Approvals